Bristol-based Spicy Minds Ltd Secures £180k in Latest Funding Round

Spicy Minds Ltd, a Bristol-based digital health company leveraging artificial intelligence to provide mental health and neurodiversity support, has successfully raised £180k in its latest funding round. This new investment brings the company's post-money valuation to £1.3m. The allotment date for this round was March 31, 2026, with the filing date on April 16, 2026. The specific investors participating in this round were not disclosed.

Founded on March 9, 2023, Spicy Minds Ltd addresses the growing need for personalised support for individuals and families navigating mental health challenges and neurodivergent traits such as autism and ADHD. The company develops AI-powered applications, notably Sylva and Rowan, designed to offer tailored strategies and emotional guidance. Sylva, for instance, is an autism and ADHD family support app built by parents and developed with input from clinicians and researchers. It uses AI to power four specialist mentors—Hazel, Luna, Fern, and Rowan—each focusing on different aspects of family life to help parents build confidence, create a calmer home, and advocate for their children. Rowan also assists users in understanding their own underlying issues. The company currently operates with a lean team of one employee.

This recent £180k funding round marks a continued growth trajectory for Spicy Minds Ltd. It follows a previous seed round completed on March 31, 2024, which saw the company raise £200k at a post-money valuation of £700k. The latest investment, while slightly smaller in size, demonstrates an increase in valuation, reflecting progress since its initial seed funding.

The funding round for Spicy Minds Ltd occurs within a dynamic UK digital health landscape, where AI-driven solutions are attracting significant investment. The European digital health funding landscape experienced a notable 52% year-on-year increase in the first half of 2025, reaching $3.4 billion across 182 deals, a trend that runs contrary to a global decline in digital health funding during the same period. The UK's HealthTech sector has been a key contributor to this regional strength.

Artificial intelligence has emerged as a dominant force in the sector, with over 60% of companies in early-stage deals explicitly leveraging AI in 2025. By the second quarter of 2025, AI-focused startups captured 69% of all digital health funding, a substantial increase from 41% in 2024. This highlights a shift towards practical deployment of AI to address specific pain points in healthcare. The UK digital health market itself was valued at an estimated USD 15.46 billion in 2025 and is projected to grow to USD 43.98 billion by 2031, with Healthcare Analytics & AI leading this growth at a compound annual growth rate of 19.80%.

Spicy Minds Ltd's focus on AI-powered personalised support for neurodiversity and mental health aligns directly with these prevailing market trends, positioning the company within a high-growth segment of the UK's digital health economy. As the market continues to mature, with capital becoming more disciplined and focused on solutions demonstrating measurable impact, Spicy Minds Ltd's ability to secure follow-on funding underscores investor confidence in its mission and technological approach.